Date | Time | Source | Announcement |
---|---|---|---|
14 May 2024 | 12:05 PM | Holding(s) in Company | |
03 May 2024 | 03:31 PM | Holding(s) in Company | |
02 May 2024 | 09:00 AM | Holding(s) in Company | |
22 Apr 2024 | 03:39 PM | Holding(s) in Company | |
18 Apr 2024 | 05:33 PM | Director/PDMR Shareholding | |
17 Apr 2024 | 03:07 PM | Holding(s) in Company | |
10 Apr 2024 | 03:10 PM | Holding(s) in Company | |
10 Apr 2024 | 09:47 AM | Holding(s) in Company | |
09 Apr 2024 | 09:00 AM | Holding(s) in Company | |
08 Apr 2024 | 09:00 AM | Holding(s) in Company | |
03 Apr 2024 | 05:16 PM | Holding(s) in Company | |
02 Apr 2024 | 09:01 AM | Holding(s) in Company | |
02 Apr 2024 | 09:00 AM | Holding(s) in Company | |
27 Mar 2024 | 01:46 PM | Holding(s) in Company | |
22 Mar 2024 | 03:11 PM | Holding(s) in Company | |
21 Mar 2024 | 12:13 PM | Director/PDMR Shareholding | |
20 Mar 2024 | 07:00 AM | Johnson Matthey sale of Medical Device Components | |
18 Mar 2024 | 03:05 PM | Holding(s) in Company | |
18 Mar 2024 | 02:32 PM | Holding(s) in Company | |
12 Mar 2024 | 05:12 PM | Holding(s) in Company | |
12 Mar 2024 | 09:00 AM | Holding(s) in Company | |
11 Mar 2024 | 09:00 AM | Holding(s) in Company | |
07 Mar 2024 | 04:20 PM | Holding(s) in Company | |
22 Feb 2024 | 04:53 PM | Director/PDMR Shareholding | |
20 Feb 2024 | 03:57 PM | Holding(s) in Company | |
19 Feb 2024 | 03:12 PM | Holding(s) in Company | |
15 Feb 2024 | 09:54 AM | Director/PDMR Shareholding | |
09 Feb 2024 | 04:17 PM | Holding(s) in Company | |
09 Feb 2024 | 12:31 PM | Director/PDMR Shareholding | |
08 Feb 2024 | 02:17 PM | Holding(s) in Company | |
08 Feb 2024 | 02:17 PM | Holding(s) in Company | |
01 Feb 2024 | 04:08 PM | Holding(s) in Company | |
29 Jan 2024 | 03:22 PM | Holding(s) in Company | |
29 Jan 2024 | 02:37 PM | Holding(s) in Company | |
29 Jan 2024 | 02:37 PM | Holding(s) in Company | |
29 Jan 2024 | 02:35 PM | Holding(s) in Company | |
23 Jan 2024 | 04:47 PM | Holding(s) in Company | |
19 Jan 2024 | 02:18 PM | Holding(s) in Company | |
18 Jan 2024 | 02:30 PM | Holding(s) in Company | |
18 Jan 2024 | 11:54 AM | Director/PDMR Shareholding | |
10 Jan 2024 | 01:29 PM | Holding(s) in Company | |
09 Jan 2024 | 01:31 PM | Holding(s) in Company | |
05 Jan 2024 | 04:50 PM | Holding(s) in Company | |
04 Jan 2024 | 04:26 PM | Holding(s) in Company | |
02 Jan 2024 | 03:27 PM | Holding(s) in Company | |
28 Dec 2023 | 01:35 PM | Holding(s) in Company | |
21 Dec 2023 | 01:25 PM | Director/PDMR Shareholding | |
19 Dec 2023 | 02:29 PM | Holding(s) in Company | |
15 Dec 2023 | 09:00 AM | Holding(s) in Company | |
13 Dec 2023 | 03:01 PM | Holding(s) in Company |
Johnson Matthey Plc, traded as JMAT on the London Stock Exchange (LSE), is a British multinational speciality chemicals and sustainable technologies company.
Founded in 1817 by Percival Norton Johnson as a gold assayer in London, George Matthey joined the business in 1851, and the name was changed to Johnson & Matthey. The following year, the firm was appointed the official assayer and refiner to the Bank of England. Over the years, Johnson Matthey has expanded its holdings and made several acquisitions.
Today, it operates in over 30 countries and employs over 12,000 staff. Johnson Matthey is a constituent of the FTSE 250 Index on the London Stock Exchange Group (LSEG).
The company's portfolio includes emission control catalysts, industrial catalysts, absorbents, process technologies, fine chemicals, active pharmaceutical ingredients, chemical products, medical device components, colours, coatings, fuel cell technology, and battery technology¹. This evergreen company continues to focus on delivering high-quality products and sustainable technologies.
Johnson Matthey share price listed on LSE at 466p in 1993.